meglumine and technetium tc 99m hydroxymethylene diphosphonate

meglumine has been researched along with technetium tc 99m hydroxymethylene diphosphonate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benhaiem, N; Damy, T; Deux, JF; Itti, E; Kobeiter, H; Legou, F; Luciani, A; Planté-Bordeneuve, V; Rahmouni, A; Rappeneau, S; Rosso, J; Tacher, V	1

Other Studies

1 other study(ies) available for meglumine and technetium tc 99m hydroxymethylene diphosphonate

Article	Year
Usefulness of T2 ratio in the diagnosis and prognosis of cardiac amyloidosis using cardiac MR imaging. Diagnostic and interventional imaging, 2017, Volume: 98, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Case-Control Studies; Contrast Media; Female; Heart Diseases; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Myocardial Perfusion Imaging; Organometallic Compounds; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate	2017

Article

Year

Usefulness of T2 ratio in the diagnosis and prognosis of cardiac amyloidosis using cardiac MR imaging.

Diagnostic and interventional imaging, 2017, Volume: 98, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Case-Control Studies; Contrast Media; Female; Heart Diseases; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Myocardial Perfusion Imaging; Organometallic Compounds; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate

2017